LAM_Journeys_Blog-01-01

Search for an Article

 Search

To search by keyword(s), simply type the words in the search box and click Search.

To search for a specific phrase, enter the phrase within quotation marks and click Search.

To search for predetermined topics/tags or by type of resource, scroll down until you see the category and tags sections on the left navigation bar of this page. Then click on the category or topic of interest to reveal the corresponding videos.

Topic

Featured Article

Michigan 2.jpg

Fighting for a LAM Diagnosis and Now a Cure

Posted on August 05, 2022   |   

For seven years, I continually searched for answers because I knew something was wrong with my health. I had a hard time breathing and started coughing up blood clots with exertion or exercise. I went to several pulmonologists, but no one could find anything. On a family trip to Greece in 2014, I had a severe episode while swimming with my daughters. I couldn’t breathe, I became dizzy and almost passed out.  I spent two days in bed without being able to move. The

Read More

Categories: Patient Profiles

Recent Articles

Articles for tag Research

biomarkers.jpg

Short-Term Goals, Long-Term Effects: Outcomes of the 2017 LAM Patient Benefit Conference

Posted on November 30, 2018   |   

How can we improve the lives of LAM patients in five years or less? This is the question scientists, clinicians, and patients themselves gathered to answer at the first-ever LAM Patient Benefit Conference. Among the many valuable ideas shared, the following grant proposals have received funding to move forward. Each was chosen for its potential to result in solutions that will positively impact the diagnosis, care, or quality of life of LAM patients by the year 2023.

Read More

Topics: Patient Benefit Conference Research        Categories: Events News

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with LAM

Posted on November 21, 2017   |   

Lymphangioleiomyomatosis (LAM) predominantly affects women and can worsen with pregnancy, estrogen treatment, and the menstrual cycle, which suggested an important role for estrogen in the development and progression of this disease.

In preclinical laboratory studies, estrogen appeared to promote the growth and spread of LAM-like cells, while suppression of estrogen reduced the survival of LAM cells. In other human clinical trials, there has been a suggestion that lung function declines more slowly in LAM patients after menopause, although this was not clear when this clinical trial was being developed.

Read More

Topics: Research        Categories: Educational Resources

Pulmonary Lymphangioleiomyomatosis (LAM): A Monogenic Neoplasm That Provides a Window into Cancer

Posted on November 21, 2017   |   

The LAM community including LAM researchers, clinicians and patients has made incredible progress over the last 20 years. Frank McCormack and I were honored to write an invited review article “Lymphangioleiomyomatosis: A Monogenic Model of Malignancy” for the prestigious The Annual Review of Medicine, which covers significant developments in various fields of medicine since 1950.

Read More

Topics: Research        Categories: Educational Resources
1 2